VISCHER AG has advised Oculis Holding AG. Oculis Holding AG, a global biopharmaceutical company listed on Nasdaq and XICE, has announced the successful pricing of offerings...
Oculis Holding AG Secures USD 110 Million Through Share Offerings
Invariant Labs Sold to Snyk
Wenger Vieli has advised the shareholders of Invariant Labs. VISCHER advised Snyk. The shareholders of Invariant Labs, a Zurich-based artificial intelligence security research firm and spin-off...
Easternmed Real Estate Capital Acquires Prime Hotel Residence in Geneva
VISCHER has advised Easternmed Real Estate Capital PLC. Easternmed Real Estate Capital PLC, a company listed on the Cyprus Stock Exchange Emerging Markets, has completed the...
Santis Pharma’s Investment Round From Abenex
VISCHER acted as Swiss counsel to Santis Pharma in collaboration with lead counsel Archers Avocats. Santis Pharma, a Franco-Swiss laboratory company developing and marketing food supplements...
Constructor Group’s Corporate Reorganization in Switzerland
VISCHER advised Constructor Group on the operation. Through its for-profit and nonprofit entities that combine notably a university, a research center, businesses, consulting services, incubation, and...
Helsinn’s Financing Agreement with Oberland Capital
VISCHER advised Oberland Capital in this transaction. Oberland Capital Management LLC signed a financing agreement with the Helsinn Group. Oberland Capital is a private investment firm...
E3 Holding AG’s Acquisition of Clean-tek Gruppe
VISCHER acted as lead counsel to the buyer. Heuking Kühn Lüer Wojtek advised NORD/LB Norddeutsche Landesbank – Girozentrale. E3 Holding AG, Germany, has acquired the clean-tek...
Invision’s CHF 145 Million Continuation Fund Closing
Niederer Kraft Frey and Vischer advised Invision on the deal. Invision, a leading investment group, announced the launch and successful closing of Invision Logistics LP, a...
Dermavant Sciences’ $200 Million Financing
VISCHER acted as Swiss counsel to Dermavant in the transaction. Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, entered...